1. 1117TiPIMvoke010: Randomized phase III study of atezolizumab (atezo) as adjuvant monotherapy after definitive therapy of squamous cell carcinoma of the head and neck (SCCHN). (23rd October 2018) Authors: Haddad, R; Wong, D J; Guo, Y; Fayette, J; Cohen, E E W; Kowgier, M; Sandler, A; Matheny, C; Kabbinavar, F; Raben, D Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗